2001 Chemotherapy Compounding 
The Checkup by Singlecare
AUGUST 8, 2024
Drug shortages in the United States are extremely common, with the number of ongoing and active shortages at their highest since the American Society of Health-System Pharmacists (ASHP) began tracking in 2001. However, if this isn’t an option, pharmacists may need to consider outsourcing to a compounding pharmacy.
Pharmaceutical Technology
FEBRUARY 13, 2023
The first concept for a PROTAC was published in 2001, and recently these protein degraders have gained rapid momentum as a promising novel modality. This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Thyroid Pharmacist
NOVEMBER 4, 2022
While the human body (via the liver and kidneys) can produce up to 4 g/day of inositol, it has been found that the overly processed, high glucose (and low fiber) Western diets that many people follow, only provide about 1 g/day of the compound. (7). Some people actually went into remission after starting the myo-inositol. Endokrynol Pol.
The Thyroid Pharmacist
SEPTEMBER 20, 2024
Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Published January 2001.
The FDA Law Blog
FEBRUARY 11, 2024
Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. The letter is signed by six former DEA administrators and five former Directors of National Drug Policy. The earliest tenured is John Bartels, who served as Administrator from 1973 to 1975.
Expert insights. Personalized for you.
52 
Let's personalize your content